Cathie Wood's Ark Genomic Revolution ETF owns $50 million worth of Recursion Pharmaceuticals stock.
In December 2022, the Federal Reserve announced the seventh consecutive increase to the federal funds rate and indicated it intented to continue raising interest rates going forward. The Fed has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results